Human Chorionic Gonadotropin is used to treat adult males who have selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) and for the induction of ovulation and pregnancy in the anovulatory, for infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins.
Human Chorionic Gonadotropin stimulates production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of the testis to produce androgens and the corpus luteum of the ovary to produce progesterone.
Human Chorionic Gonadotropin should be used in conjunction with human menopausal gonadotropins only by physicians experienced with infertility problems who are familiar with the criteria for patient selection, contraindications, warnings, precautions and adverse reactions described in the package insert for menotropins. The principal serious adverse reactions are: (1) Ovarian hyperstimulation, a syndrome of sudden ovarian enlargement, ascites with or without pain and/or pleural effusion, (2) Rupture of ovarian cysts with resultant hemoperitoneum, (3) Multiple births and (4) Arterial thromboembolism.
Anaphylaxis and other hypersensitivity reactions have been reported with urinary-derived HCG products.
If you are concerned that you are having side effects related to the medication, please consult your doctor.
Click here for full Prescribing Information and Patient Information.
